Prospective Cohort Study Comparing Varying Doses of Cisatracurium and Atracurium on Intubating Conditions in Patients Undergoing Laparoscopic Cholecystectomy [PDF]
Introduction: Cisatracurium and atracurium are nondepolarising muscle relaxants belonging to benzylisoquinolinium group. Intubating dose of cisatracurium is found to be safer than atracurium owing to the histamine release and resultant respiratory and
Chandrasekharan Anjali +2 more
doaj +1 more source
Comparison of Different Neostigmine Doses for Reversal of Cisatracurium-Induced Neuromuscular Block in Children Under Total Intravenous Anesthesia: A Randomized Controlled Trial. [PDF]
ABSTRACT Background Neostigmine is widely used to reverse nondepolarizing neuromuscular blockade in children, but the optimal dose under total intravenous anesthesia is uncertain. Aims The primary aim was to compare the time to full neuromuscular recovery (TOF ratio of 1.0) following administration of neostigmine at doses of 0, 10, 20, and 30 μg/kg in ...
Neto AJMM +7 more
europepmc +2 more sources
Polarized Light Microscopy for Quantitative Assessment of Sarcomere-Scale Structural Order in Cardiac Tissue. [PDF]
Impact of cardiac and respiratory arrest on cardiac muscle tissue. Wistar rats were injected (on the left) either with cisatracurium to induce a respiratory arrest or lidocaine to induce a cardiac arrest (in the middle). Further, the pathophysiological changes developed and were assessed with linear polarization microscopy at 600–3000 nm wavelength ...
Piavchenko G +12 more
europepmc +2 more sources
Cisatracurium – A “safe” neuromuscular blocking agent? [PDF]
Anesthetic agents are an important cause of drug anaphylaxis, with neuromuscular blocking agents (NMBA) being a common cause of intraoperative anaphylaxis.
Gonçalves, Tânia +4 more
core +1 more source
Antagonist of Chrna1 prevents the pathogenesis of primary focal hyperhidrosis
Background Primary focal hyperhidrosis (PFH) is an autonomic neurological disease in which exocrine glands are oversecreted due to autonomic dysfunction of the sympathetic nervous system. Chrna1 promotes the pathogenesis of PFH.
Jian‐Bo Lin +3 more
doaj +1 more source
Background: Stability study of a 10 mg/mL injectable cisatracurium solution stored refrigerated in amber glass ampoules for 18 months (M18). Methods: 4000 ampoules were aseptically compounded using European Pharmacopoeia (EP)-grade cisatracurium besylate,
Marine Roche +7 more
doaj +1 more source
Anaphylactic reactions after cisatracurium administration in two patients -a report of two cases- [PDF]
Cisatracurium was initially characterized to have no evident histamine-releasing potential with excellent cardiovascular stability. However, severe anaphylactic reactions to cisatracurium that resulted in bronchospasms and cardiovascular collapse have ...
Yangin Yoon +5 more
doaj +1 more source
The effect of low dose ketamine and priming of cisatracurium on the intubating condition and onset time of cisatracurium [PDF]
BackgroundBoth ketamine and priming may accelerate the onset time of neuromuscular blocking agents. We investigate the effect of low dose ketamine and cisatracurium priming on the intubating condition and onset time of cisatracurium.MethodsAfter ...
Byung-Ryang Ahn +4 more
doaj +1 more source
Effects and safety of continuous infusion of cisatracurium in laparoscopic abdominal surgery [PDF]
Objective To explore the effects and safety of continuous infusion of cisatracurium in laparoscopic abdominal surgery. Methods Ninety patients undergoing elective laparoscopic abdominal surgery in Gubei Branch of Ruijin Hospital from January 2019 to ...
ZHU Qianlin, LI Kai, ZI Yuqiang, JIN Weifang
doaj +1 more source
Use of cisatracurium in critical care: a review of the literature
Cisatracurium is currently one of the most commonly used neuromuscular blocking agent (NMBA) in intensive care units. Cisatracurium was developed primarily for anaesthetic purposes in order to attempt to resolve some of the problems associated with ...
Szakmany, Tamas, Woodhouse, Thomas
core +6 more sources

